Suppr超能文献

全国范围内实施人口管理仪表板以监测直接口服抗凝剂:来自退伍军人事务部卫生系统的见解。

Nationwide Implementation of a Population Management Dashboard for Monitoring Direct Oral Anticoagulants: Insights From the Veterans Affairs Health System.

机构信息

College of Pharmacy (M.P.D.), University of Michigan, Ann Arbor.

Frankel Cardiovascular Center (M.P.D., G.D.B.), University of Michigan, Ann Arbor.

出版信息

Circ Cardiovasc Qual Outcomes. 2023 Feb;16(2):e009256. doi: 10.1161/CIRCOUTCOMES.122.009256. Epub 2022 Dec 9.

Abstract

BACKGROUND

Direct oral anticoagulants are first-line therapy for common thrombotic conditions, including atrial fibrillation and venous thromboembolism. Despite their strong efficacy and safety profile, evidence-based prescribing can be challenging given differences in dosing based on indication, renal function, and drug-drug interactions. The Veterans Health Affairs developed and implemented a population management dashboard to support pharmacist review of anticoagulant prescribing. The dashboard includes information about direct oral anticoagulants and dose prescribed, renal function, age, and weight, potential interacting medications, and the need for direct oral anticoagulant medication refills. It is a stand-alone system.

METHODS

Using login data from the dashboard, nationwide implementation was evaluated using elements from the Reach, Effectiveness, Adoption, Implementation, and Maintenance framework.

RESULTS

Between August 2016 and June 2020, 150/164 sites within the Veterans Health Affairs system used the dashboard, averaging 1875 patients per site. The dashboard was made available to sites on a staggered basis. Moderate or high adoption, defined as at least one login on at least 2 separate days per month, began slowly with 3/5 sites in the pilot phase but rapidly grew to 142/150 (94.7%) sites by June 2020. The average number of unique users per site increased from 2.4 to 7.5 over the study period. Moderate to high adoption of the dashboard's use was maintained for > 6 months in 126/150 (84.0%) sites by the end of the study period.

CONCLUSIONS

There was rapid and sustained implementation and adoption of a population health dashboard for evidence-based anticoagulant prescribing across the national United States Veterans Health Administration health system. The impact of this tool on clinical outcomes and strategies to replicate this care model in other health systems will be important for broad dissemination and uptake.

摘要

背景

直接口服抗凝剂是治疗常见血栓性疾病(包括心房颤动和静脉血栓栓塞症)的一线治疗药物。尽管它们具有强大的疗效和安全性,但鉴于剂量因适应症、肾功能和药物相互作用而异,基于证据的处方可能具有挑战性。退伍军人事务部开发并实施了一种人群管理仪表板,以支持药剂师审查抗凝药物的处方。该仪表板包括有关直接口服抗凝剂和处方剂量、肾功能、年龄和体重、潜在相互作用药物以及直接口服抗凝药物补充的信息。它是一个独立的系统。

方法

使用仪表板的登录数据,根据 Reach、Effectiveness、Adoption、Implementation 和 Maintenance 框架的元素评估全国范围内的实施情况。

结果

在 2016 年 8 月至 2020 年 6 月期间,退伍军人事务部系统内的 150/164 个站点使用了该仪表板,平均每个站点有 1875 名患者。该仪表板分阶段提供给各站点。中度或高度采用定义为每月至少有 2 天至少登录一次,在试点阶段有 3/5 的站点采用率较低,但到 2020 年 6 月迅速增长到 142/150(94.7%)站点。在研究期间,每个站点的独特用户平均数量从 2.4 增加到 7.5。在研究结束时,150 个站点中有 126 个(84.0%)站点保持了对仪表板使用的中高度采用超过 6 个月。

结论

在美国退伍军人事务部全国卫生系统中,快速且持续地实施和采用了人群健康仪表板,以实现基于证据的抗凝药物处方。该工具对临床结果的影响以及在其他卫生系统中复制这种护理模式的策略,对于广泛传播和采用将是重要的。

相似文献

引用本文的文献

本文引用的文献

6
The Impact of Strong Inducers on Direct Oral Anticoagulant Levels.强诱导剂对直接口服抗凝剂水平的影响。
Am J Med. 2021 Oct;134(10):1295-1299. doi: 10.1016/j.amjmed.2021.06.003. Epub 2021 Jun 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验